Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer

1. Paz-Ares, L.G.
2. Biesma, B.
3. Heigener, D.
4. Von Pawel, J.
5. Eisen, T.
6. Bennouna, J.
7. Zhang, L.
8. Liao, M.
9. Sun, Y.
10. Gans, S.
11. Syrigos, K.
12. Le Marie, E.
13. Gottfried, M.
14. Vansteenkiste, J.
15. Alberola, V.
16. Strauss, U.P.
17. Montegriffo, E.
18. Ong, T.J.
19. Santoro, A.